News

Vitamin D appears protective in patients with metastatic colorectal cancer

Publish date: January 17, 2015

 

AT THE 2015 GASTROINTESTINAL CANCERS SYMPOSIUM

References

The research was supported by the National Cancer Institute. Dr. Krishnamurthi had no relevant disclosures. Many of Dr. Ng’s coauthors reported financial ties to multiple companies, including Bristol-Myers Squibb, which funded the CALGB 80405 trial.

Pages

Recommended Reading

Clinical factors associated with IBD can increase risk of CMV disease
MDedge Family Medicine
Sofosbuvir and ribavirin critical to preventing posttransplantation HCV recurrence
MDedge Family Medicine
HCV continuum critical to providing better care in urban areas
MDedge Family Medicine
FDA approves IV antibacterial for complicated UTIs, abdominal infections
MDedge Family Medicine
Gilead’s hepatitis C drugs to be sold exclusively at CVS
MDedge Family Medicine
Microbiota organization influences colorectal cancers
MDedge Family Medicine
Outcomes of stage III colon cancer appear better for aspirin, COX-2 inhibitor users
MDedge Family Medicine
Analysis: Push for expanded hepatitis C screening appears premature
MDedge Family Medicine
FDA approves vagal blocking device for obesity
MDedge Family Medicine
Aetna customers to receive discount on Gilead’s hepatitis C treatment
MDedge Family Medicine